Landmark Australian Trial Finds Statins Lower Major Heart Risks in Adults Over 70
Melbourne, A major Australian clinical trial has produced new evidence that could influence how doctors approach cholesterol-lowering treatment in older...
Cholesterol
FDA Approves Lipfendra, the First Once-Daily Oral PCSK9 Inhibitor for Lowering LDL Cholesterol
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily oral medication designed to help adults lower...
